# Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection

> **NCT07128888** · PHASE1 · RECRUITING · sponsor: **Gan & Lee Pharmaceuticals.** · enrollment: 60 (estimated)

## Conditions studied

- Obesity or Overweight

## Interventions

- **DRUG:** GZR18 injection,digoxin tablets, rosuvastatin calcium tablets and warfarin sodium tablets

## Key facts

- **NCT ID:** NCT07128888
- **Lead sponsor:** Gan & Lee Pharmaceuticals.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-17
- **Primary completion:** 2026-07-05
- **Final completion:** 2026-07-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07128888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07128888, "Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07128888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*